Globus Medical’s full-year revenue for 2025 is projected to reach nearly $3 billion, according to preliminary financial results.
Full-year revenue in 2025 is expected to increase 25.2% year over year with sales of $2.94 billion, according to a Jan. 7 news release. Fourth-quarter sales are anticipated to reach $823.2 million, a 25.2% increase.
Preliminary results are unaudited and based on an initial analysis of operations.
“Globus closed 2025 with strong momentum, delivering meaningful revenue growth across the business, while advancing operational priorities and integrating the Nevro acquisition,” Keith Pfeil, president and CEO, said in the release. “Fourth quarter results reflected the continued trend of growth and market share gains within US Spine, while Enabling Technologies delivered its best quarterly revenue performance to date. We look to 2026 with confidence, remaining focused on driving innovation and operational excellence, introducing a robust pipeline of new products, maintaining disciplined investment and executing our strategy of sustained, profitable growth.”
Globus Medical’s final financial report for the fourth quarter and full-year of 2025 is scheduled for Feb. 24.
